CAMP and ST Elevation Myocardial Infarction: A prospective study conducted by Zhao et al. reported that high basal plasma levels of LL37/ hCAP18 predict a lower risk of atherosclerosis-induced cardiovascular events in patients after ST-elevation myocardial infarction (75).